Cargando…
A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson
The novel coronavirus outbreak was declared a pandemic in March 2020. We are reviewing the COVID-19 vaccines authorized for use in the United States by discussing the mechanisms of action, administration, side effects, and efficacy of vaccines developed by Pfizer, Moderna, and Johnson & Johnson....
Autores principales: | Patel, Rikin, Kaki, Mohamad, Potluri, Venkat S., Kahar, Payal, Khanna, Deepesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862159/ https://www.ncbi.nlm.nih.gov/pubmed/35130825 http://dx.doi.org/10.1080/21645515.2021.2002083 |
Ejemplares similares
-
M015 A PATIENT WITH AN ALLERGIC REACTION TO THE PFIZER COVID-19 VACCINE SUBSEQUENTLY TOLERATES JOHNSON&JOHNSON VACCINATION
por: Patterson, A., et al.
Publicado: (2021) -
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021
por: Self, Wesley H., et al.
Publicado: (2021) -
Widespread cutaneous reaction to the Johnson & Johnson Ad26.COV2.S vaccine
por: Sowell, Josiah, et al.
Publicado: (2021) -
A Case Report of DVT following the Johnson and Johnson Vaccine against the Novel SARS-CoV-2
por: Bangolo, Ayrton, et al.
Publicado: (2022) -
Reply to “Widespread Cutaneous Reaction to the Johnson & Johnson Ad26.Cov2.S Vaccine”
por: Malachowski, Stephen J., et al.
Publicado: (2022)